SenzaGen AB (STO:SENZA)
Sweden · Delayed Price · Currency is SEK 4.990
-0.010 (-0.20%)
Sep 3, 2026, 10:32 AM CET
SenzaGen AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 61.05 | 57.97 | 57.7 | 49.87 | 41.77 | 15.42 | |
Revenue Growth | 9.33% | 0.48% | 15.69% | 19.39% | 170.85% | 93.79% |
Cost of Revenue | 21.95 | 20.41 | 19.1 | 14.94 | 14.43 | 5.97 |
Gross Profit | 39.1 | 37.57 | 38.59 | 34.93 | 27.34 | 9.45 |
Selling, General & Admin | 46.15 | 45.41 | 46.2 | 45.93 | 39.03 | 36.78 |
Research & Development | 3.16 | 3.66 | 7.07 | 3.75 | 8.99 | 3.87 |
Other Operating Expenses | -1.56 | -0.49 | -2 | 0.23 | -0.49 | 0.04 |
Operating Expenses | 47.76 | 48.58 | 51.28 | 49.9 | 47.53 | 40.69 |
Operating Income | -8.66 | -11.01 | -12.68 | -14.97 | -20.19 | -31.24 |
Interest Expense | -0.97 | -0.82 | -0.77 | -0.04 | -0.05 | -0.02 |
Interest & Investment Income | 0.61 | 0.59 | 0.82 | 0.56 | 0.17 | 0.08 |
Currency Exchange Gain (Loss) | -1.02 | -1.02 | 0.11 | - | - | - |
Other Non Operating Income (Expenses) | -0.02 | -0.02 | - | -0.02 | 0.02 | 0.11 |
EBT Excluding Unusual Items | -10.06 | -12.29 | -12.53 | -14.46 | -20.04 | -31.07 |
Merger & Restructuring Charges | - | - | - | -7.52 | -4.92 | -0.29 |
Other Unusual Items | 0.45 | 0.45 | 0.75 | - | - | - |
Pretax Income | -9.61 | -11.83 | -11.77 | -21.98 | -24.96 | -31.37 |
Income Tax Expense | -0.36 | -0.25 | -0.56 | 0.12 | -0.05 | -0.02 |
Earnings From Continuing Operations | -9.25 | -11.59 | -11.22 | -22.1 | -24.91 | -31.35 |
Net Income | -9.25 | -11.59 | -11.22 | -22.1 | -24.91 | -31.35 |
Net Income to Common | -9.25 | -11.59 | -11.22 | -22.1 | -24.91 | -31.35 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 30 | 30 | 27 | 24 | 24 | 23 |
Shares Outstanding (Diluted) | 30 | 30 | 27 | 24 | 24 | 23 |
Shares Change | -4.07% | 8.12% | 12.82% | 0.43% | 3.99% | 8.45% |
EPS (Basic) | -0.31 | -0.39 | -0.41 | -0.91 | -1.03 | -1.35 |
EPS (Diluted) | -0.31 | -0.39 | -0.41 | -0.91 | -1.03 | -1.35 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -6.75 | -9.84 | -7.13 | -16.58 | -16.68 | -21.31 |
Free Cash Flow Per Share | -0.23 | -0.33 | -0.26 | -0.69 | -0.69 | -0.92 |
Gross Margin | 64.04% | 64.80% | 66.89% | 70.05% | 65.44% | 61.30% |
Operating Margin | -14.19% | -19.00% | -21.98% | -30.01% | -48.34% | -202.57% |
Profit Margin | -15.15% | -19.99% | -19.44% | -44.31% | -59.64% | -203.25% |
Free Cash Flow Margin | -11.05% | -16.96% | -12.36% | -33.25% | -39.93% | -138.19% |
EBITDA | -1.8 | -4.45 | -6.79 | -6.78 | -14.08 | -29.09 |
EBITDA Margin | -2.95% | -7.68% | -11.77% | -13.60% | -33.70% | -188.62% |
D&A For EBITDA | 6.86 | 6.56 | 5.89 | 8.19 | 6.11 | 2.15 |
EBIT | -8.66 | -11.01 | -12.68 | -14.97 | -20.19 | -31.24 |
EBIT Margin | -14.19% | -19.00% | -21.98% | -30.01% | -48.34% | -202.57% |